Societe Generale SA Form 8.3 - Willis Towers Watson plc (5735G)
27 Julho 2021 - 3:00AM
UK Regulatory
TIDMIRSH TIDM0Y4Q
RNS Number : 5735G
Societe Generale SA
27 July 2021
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Société Générale
(Note 1) S.A.
Company dealt in Willis Towers Watson plc
======================================
Class of relevant security US$0.000304635 ordinary
to which the dealings shares
being disclosed relate
(Note 2)
======================================
Date of dealing 26/07/2021
======================================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
----------- ------ -------- -----
(1) Relevant securities 1,582,683 1.23 5,007 0.00
----------- ------ -------- -----
(2) Derivatives (other
than options) 146 0.00 599,369 0.46
----------- ------ -------- -----
(3) Options and agreements
to purchase/sell 0 0.00 0 0.00
----------- ------ -------- -----
Total *2,595,072 *2.01 604,376 0.47
----------- ------ -------- -----
* Include the holding of 1,012,243 shares on borrow products
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant Long Short
security:
Number (%) Number (%)
------- ---- ------- ----
(1) Relevant securities
------- ---- ------- ----
(2) Derivatives
(other than options)
------- ---- ------- ----
(3) Options and
agreements to purchase/sell
------- ---- ------- ----
Total
------- ---- ------- ----
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant Price per unit
securities USD (Note 5)
Purchase 100 206.92
------------------- ---------------
Purchase 100 209.41
------------------- ---------------
Purchase 100 206.7
------------------- ---------------
Purchase 45 213.38
------------------- ---------------
Purchase 27 213.38
------------------- ---------------
Purchase 8 213.38
------------------- ---------------
Purchase 1,200 206.07
------------------- ---------------
Purchase 381 206.07
------------------- ---------------
Purchase 4 206.16
------------------- ---------------
Purchase 10 206.16
------------------- ---------------
Purchase 55 215
------------------- ---------------
Purchase 69 214.29
------------------- ---------------
Purchase 26 211.06
------------------- ---------------
Purchase 74 211.06
------------------- ---------------
Purchase 100 211
------------------- ---------------
Purchase 17 213.71
------------------- ---------------
Purchase 100 206.37
------------------- ---------------
Sale 24 211
------------------- ---------------
Sale 12 213.58
------------------- ---------------
Sale 100 210.23
------------------- ---------------
Sale 24 211
------------------- ---------------
Sale 26 211.55
------------------- ---------------
Sale 74 211.55
------------------- ---------------
Sale 10 210.53
------------------- ---------------
Sale 19 212.67
------------------- ---------------
Sale 16 213.05
------------------- ---------------
Sale 11 210.52
------------------- ---------------
Sale 12 212.4
------------------- ---------------
Sale 12 212.41
------------------- ---------------
Sale 12 212.41
------------------- ---------------
Sale 37 212.45
------------------- ---------------
Sale 1 212.41
------------------- ---------------
Sale 29 212.41
------------------- ---------------
Sale 5 212.41
------------------- ---------------
Sale 10 212.41
------------------- ---------------
Sale 23 212.45
------------------- ---------------
Sale 12 212.42
------------------- ---------------
Sale 6 212.4
------------------- ---------------
Sale 11 212.42
------------------- ---------------
Sale 39 212.42
------------------- ---------------
Sale 39 212.41
------------------- ---------------
Sale 16 212.4
------------------- ---------------
Sale 18 212.4
------------------- ---------------
Sale 52 212.41
------------------- ---------------
Sale 6 212.42
------------------- ---------------
Sale 100 206.14
------------------- ---------------
Sale 100 206.1
------------------- ---------------
Sale 508 206.07
------------------- ---------------
Sale 14,800 206.07
------------------- ---------------
Sale 5 215
------------------- ---------------
Sale 76 215
------------------- ---------------
Sale 1,596 206.07
------------------- ---------------
Sale 760 206.07
------------------- ---------------
Purchase/sale Number of relevant Price per unit
securities EUR (Note 5)
------------------- ---------------
Sale 40 188
------------------- ---------------
Total Purchases 2,416
------------------- ---------------
Total Sales 18,641
------------------- ---------------
Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of Price per
e.g. CFD (Note 6) relevant unit USD
securities (Note
(Note 7) 5)
CFD Decreased short 340 212.375
----------------------- ------------ ----------
(b) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money
e.g. call purchasing, to which European paid/received
option varying the option etc. per unit
etc. relates (Note (Note
7) 5)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(c) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other
person relating to the voting rights of any relevant securities
under any option referred to on this
form or relating
to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred
to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) No
Date of disclosure 27/07/2021
Contact name Société Générale
- Disclosure team
====================================
Telephone number +33 1 42 14 92 74
====================================
If a connected EFM, name
of offeree/offeror with
which connected
====================================
If a connected EFM, state
nature of connection (Note
10)
====================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ISEFIFESDAIDFIL
(END) Dow Jones Newswires
July 27, 2021 02:00 ET (06:00 GMT)
Willis Towers Watson (LSE:0Y4Q)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Willis Towers Watson (LSE:0Y4Q)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
